Abstract
The most well-known type of focal epilepsy that is resistant to existing treatments is temporal lobe epilepsy (TLE), with seizure foci in various structures including temporal lobe, hippocampus, amygdala, entorhinal cortex, and subcortex. The most significant processes involved in the pathophysiology of temporal lobe epilepsy (TLE) are oxidative stress, inflammation, and pyroptosis. There are evidences indicating that acetyl-l-carnitine (ALC) has anti-oxidative, anti-inflammatory, and anti-pyroptotic effects. In the present study, rat model of TLE was induced by intrahippocampal kainate and animals received ALC (100 mg/kg, p.o.). ALC properly attenuated intensity of seizures and also incidence of kainate-induced status epilepticus (SE). As well, obtained findings showed that ALC can partially reverse hippocampal levels of MDA, ROS, SOD, TNFa, NF-kB, TLR4, GFAP, and caspase 1. Besides, treatment of kainate group with ALC exerted a protective effect against CA1 neuronal loss and abnormal mossy fiber sprouting (MFS). Conclusively, these results suggest that ALC is capable to attenuate kainate-induced SE which is somewhat mediated through its lowering of oxidative stress, neuroinflammation, and pyroptosis that are related to its neuroprotective effect.
Similar content being viewed by others
Availability of Data and Materials
The data sets generated and analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- ALC:
-
Acetyl-l-carnitine
- DG:
-
Dentate gyrus
- GFAP:
-
Glial fibrillary acidic protein
- GSH:
-
Reduced glutathione
- Kainate:
-
Kainic acid
- MDA:
-
Malondialdehyde
- MFS:
-
Mossy fiber sprouting
- NF-kB:
-
Nuclear factor-kappa B
- SE:
-
Status epilepticus
- ROS:
-
Reactive oxygen species
- SOD:
-
Superoxide dismutase
- SE:
-
Status epilepticus
- TLE:
-
Temporal lobe epilepsy
- TNF-α:
-
Tumor necrosis factor-α
- TBA:
-
Thiobarbituric acid
- TLR4:
-
Toll-like receptor 4
References
Afshin-Majd S, Bashiri K, Kiasalari Z, Baluchnejadmojarad T, Sedaghat R, Roghani M (2017) Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson’s disease in the rat. Biomed Pharmacother 89:1–9
Allone C, Bonanno L, Buono VL, Corallo F, Palmeri R, Micchia K, Pollicino P, Bramanti A, Marino S (2020) Neuropsychological assessment and clinical evaluation in temporal lobe epilepsy with associated cortical dysplasia. J Clin Neurosci 72:146–150
Anagnostou I, Muñoz-Mayorga D, Morales T (2021) Prolactin neuroprotective action against excitotoxic insult in the hippocampus of male mice. Peptides 135:170425
Arya A, Sethy NK, Singh SK, Das M, Bhargava K (2013) Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation. Int J Nanomed 8:4507–4520
Azam F, VV Prasad M, Thangavel N (2012) Targeting oxidative stress component in the therapeutics of epilepsy. Curr Top Med Chem 12:994–1007
Baluchnejadmojarad T, Roghani M (2013) Coenzyme q10 ameliorates neurodegeneration, mossy fiber sprouting, and oxidative stress in intrahippocampal kainate model of temporal lobe epilepsy in rat. J Mol Neurosci 49:194–201
Beck H, Yaari Y (2012) Antiepileptogenesis, plasticity of AED targets, drug resistance, and targeting the immature brain. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper’s basic mechanisms of the epilepsies. National Center for Biotechnology Information (US)
Bertoglio D, Amhaoul H, Van Eetveldt A, Houbrechts R, Van De Vijver S, Ali I, Dedeurwaerdere S (2017) Kainic acid-induced post-status epilepticus models of temporal lobe epilepsy with diverging seizure phenotype and neuropathology. Front Neurol 8:588
Bodaghi-Namileh V, Sepand MR, Omidi A, Aghsami M, Seyednejad SA, Kasirzadeh S, Sabzevari O (2018) Acetyl-l-carnitine attenuates arsenic-induced liver injury by abrogation of mitochondrial dysfunction, inflammation, and apoptosis in rats. Environ Toxicol Pharmacol 58:11–20
Brandt C, Gastens AM, Sun M, Hausknecht M, Löscher W (2006) Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 51:789–804
Brennan GP, Garcia-Curran MM, Patterson KP, Luo R, Baram TZ (2021) Multiple disruptions of glial-neuronal networks in epileptogenesis that follows prolonged febrile seizures. Front Neurol 12:615–802
Burks S, Raymick J, Robinson B, Hanig J, Sarkar S (2019) Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson’s disease mouse model: Endothelial and microglial effects. Neurosci Lett 703:86–95
Dariani S, Baluchnejadmojarad T, Roghani M (2013) Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy. J Mol Neurosci 51:679–686
Gilgun-Sherki Y, Melamed E, Offen D (2006) Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state. Curr Pharm Des 12:3509–3519
Hadera MG, McDonald T, Smeland OB, Meisingset TW, Eloqayli H, Jaradat S, Borges K, Sonnewald U (2016) Modification of astrocyte metabolism as an approach to the treatment of epilepsy: triheptanoin and acetyl-L-carnitine. Neurochem Res 41:86–95
Howard P, Twycross R, Shuster J, Mihalyo M, Rémi J, Wilcock A (2011) Anti-epileptic drugs. J Pain Symptom Manage 42:788–804
Károly N, Mihály A, Dobó E (2011) Comparative immunohistochemistry of synaptic markers in the rodent hippocampus in pilocarpine epilepsy. Acta Histochem 113:656–662
Kazak F, Yarim GF (2017) Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: involvement of brain-derived neurotrophic factor. Neurosci Lett 658:32–36
Kiasalari Z, Afshin-Majd S, Baluchnejadmojarad T, Azadi-Ahmadabadi E, Fakour M, Ghasemi-Tarie R, Jalalzade-Ogvar S, Khodashenas V, Tashakori-Miyanroudi M, Roghani M (2021) Sinomenine alleviates murine experimental autoimmune encephalomyelitis model of multiple sclerosis through inhibiting NLRP3 inflammasome. J Mol Neurosci 71:215–224
Kwon JY, Jung UJ, Kim DW, Kim S, Moon GJ, Hong J, Jeon MT, Shin M, Chang JH, Kim SR (2018) Beneficial effects of hesperetin in a mouse model of temporal lobe epilepsy. J Med Food 21:1306–1309
Lévesque M, Avoli M (2013) The kainic acid model of temporal lobe epilepsy. Neurosci Biobehav Rev 37:2887–2899
Liu D, Li S, Gong L, Yang Y, Han Y, Xie M, Zhang C (2019) Suppression of microRNA-141 suppressed p53 to protect against neural apoptosis in epilepsy by SIRT1 expression. J Cell Biochem 120:9409–9420
Maguire MJ, Hemming K, Hutton JL, Marson AG (2008) Reporting and analysis of open-label extension studies of anti-epileptic drugs. Epilepsy Res 81:24–29
Nazıroglu M (2009) Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy. Neurochem Res 34:2181–2191
Nourabadi D, Baluchnejadmojarad T, Mohamadi Zarch SM, Ramazi S, Serenjeh MN, Roghani M (2020) Fetal hypothyroidism impairs aortic vasorelaxation response in adulthood: involvement of hydrogen sulfide and nitric oxide crosstalk. J Cardiovasc Pharmacol 77:238–244
Patel DC, Tewari BP, Chaunsali L, Sontheimer H (2019) Neuron–glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci 20:282–297
Racine R, Okujava V, Chipashvili S (1972) Modification of seizure activity by electrical stimulation. 3. Mechanisms. Electroencephalogr Clin Neurophysiol 32:295–299
Rump TJ, Abdul Muneer PM, Szlachetka AM, Lamb A, Haorei C, Alikunju S, Xiong H, Keblesh J, Liu J, Zimmerman MC, Jones J, Donohue TM Jr, Persidsky Y, Haorah J (2010) Acetyl-L-carnitine protects neuronal function from alcohol-induced oxidative damage in the brain. Free Radic Biol Med 49:1494–1504
Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205
Shin E-J, Jeong JH, Chung YH, Kim W-K, Ko K-H, Bach J-H, Hong J-S, Yoneda Y, Kim HC (2011) Role of oxidative stress in epileptic seizures. Neurochem Int 59:122–137
Smeland OB, Meisingset TW, Sonnewald U (2012) Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice. Neurochem Int 61:444–454
Soares JI, Da Costa C, Ferreira MH, Andrade PA, Maia GH, Lukoyanov NV (2019) Partial depletion of septohippocampal cholinergic cells reduces seizure susceptibility, but does not mitigate hippocampal neurodegeneration in the kainate model of epilepsy. Brain Res 1717:235–246
Srivastava S, Singh D, Patel S, Singh MR (2017) Role of enzymatic free radical scavengers in management of oxidative stress in autoimmune disorders. Int J Biol Macromol 101:502–517
Tashakori-Miyanroudi M, Souresrafil A, Hashemi P, Ehsanzadeh SJ, Farrahizadeh M, Behroozi Z (2021) Prevalence of depression, anxiety, and psychological distress in patients with epilepsy during COVID-19: a systematic review. Epilepsy Behav 125:108410
Terrone G, Balosso S, Pauletti A, Ravizza T, Vezzani A (2020) Inflammation and reactive oxygen species as disease modifiers in epilepsy. Neuropharmacology 167:107742
Tian Z, Clark BL, Menard F (2019) Kainic acid-based agonists of glutamate receptors: SAR analysis and guidelines for analog design. ACS Chem Neurosci 10:4190–4198
Vezzani A, Aronica E, Mazarati A, Pittman QJ (2013) Epilepsy and brain inflammation. Exp Neurol 244:11–21
Wang ZH, Mong MC, Yang YC, Yin MC (2018) Asiatic acid and maslinic acid attenuated kainic acid-induced seizure through decreasing hippocampal inflammatory and oxidative stress. Epilepsy Res 139:28–34
Wu D, Zheng Z, Fan S, Wen X, Han X, Wang S, Wang Y, Zhang Z, Shan Q, Li MJE, Medicine T (2020) Ameliorating Effect of Quercetin on Epilepsy by Inhibition of Inflammation in Glial Cells 20:854–859
Wu Z, Xu Q, Zhang L, Kong D, Ma R, Wang L (2009) Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 34:1393
Yuen AW, Keezer MR, Sander JW (2018) Epilepsy is a neurological and a systemic disorder. Epilepsy Behav 78:57–61
Zhang NP, Liu XJ, Xie L, Shen XZ, Wu J (2019) Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Lab Invest 99:749–763
Zidan A, Hedya SE, Elfeky DM, Abdin AA (2018) The possible anti-apoptotic and antioxidant effects of acetyl l-carnitine as an add-on therapy on a relapsing-remitting model of experimental autoimmune encephalomyelitis in rats. Biomed Pharmacother 103:1302–1311
Funding
This research study was the results of PhD student thesis project that was officially approved and supported by Iran University of Medical Sciences, Tehran, Iran (Grant no. 97–03-04–12735).
Author information
Authors and Affiliations
Contributions
M.T., S.R., P.H., and M.NS. performed experiments and collected data. T.B. and M.R. planned the study, supervised the conductance of experimental tests, analyzed data, and prepared the manuscript draft. All authors read the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
All experimental procedures of this study were conducted under ethical committee supervision of Iran University of Medical sciences (Tehran, Iran) that was in accordance to NIH guidelines for the care and use of laboratory animals. All efforts were made to minimize number of animals and to lower their sufferings. Present study was approved by Institutional Ethics Committee of the Iran University of Medical Sciences (Approval ID: IR.IUMS.FMD.REC.1398.090).
Consent for Publication
All authors have read the manuscript and approved its submission.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tashakori-Miyanroudi, M., Ramazi, S., Hashemi, P. et al. Acetyl-L-Carnitine Exerts Neuroprotective and Anticonvulsant Effect in Kainate Murine Model of Temporal Lobe Epilepsy. J Mol Neurosci 72, 1224–1233 (2022). https://doi.org/10.1007/s12031-022-01999-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-022-01999-8